study	individual	group	count	intervention	measurement_type	substance	tissue	method	label	time	time_unit	value	mean	mean_pm	mean_sd	mean_se	comments	mean_unit	value_unit
FDA1995		all	12.0	GLI1iv	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1iv	0.0	hr		0.0					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1iv	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1iv	2.0	hr		0.24608412016713005					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1iv	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1iv	4.0	hr		0.4975768512159365					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1iv	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1iv	8.0	hr		0.7679992251925993					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1iv	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1iv	12.0	hr		0.8788722821608996					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1iv	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1iv	24.0	hr		0.992449644570037					count*mole/kilogram	percent
FDA1995		all	12.0	GLI1iv	recovery	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	M1+M2_recovery_GLI1iv	48.0	hr		1.0005623133135475					count*mole/kilogram	percent
